Stay updated on Subcutaneous ND0612 Infusion in Parkinson's Clinical Trial

Sign up to get notified when there's something new on the Subcutaneous ND0612 Infusion in Parkinson's Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Subcutaneous ND0612 Infusion in Parkinson's Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    A banner announces an NIH website transition and links to updates and FAQs; the study record itself remains unavailable.
    Difference
    1%
    Check dated 2026-10-24T15:10:19.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-17T14:54:11.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-10T14:58:01.000Z thumbnail image
  4. Check
    36 days ago
    Change Detected
    Summary
    A 403 Forbidden error page is now shown, with the 403 HTML elements added. The detailed study content (drug names, conditions, eligibility criteria, and trial details) has been removed from the page.
    Difference
    17%
    Check dated 2026-09-19T22:21:23.000Z thumbnail image
  5. Check
    57 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.6.5 to v3.6.6, indicating a newer build of the page content.
    Difference
    0.1%
    Check dated 2026-08-29T18:49:04.000Z thumbnail image
  6. Check
    78 days ago
    Change Detected
    Summary
    Revision label updated from v3.6.4 to v3.6.5 on the study record, indicating a metadata update. No substantive study details or eligibility criteria appear to be changed.
    Difference
    0.1%
    Check dated 2026-08-08T11:17:02.000Z thumbnail image

Stay in the know with updates to Subcutaneous ND0612 Infusion in Parkinson's Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Subcutaneous ND0612 Infusion in Parkinson's Clinical Trial page.